
Stealth BioTherapeutics Corp MITO
Annual report 2021
added 12-23-2023
Stealth BioTherapeutics Corp Operating Expenses 2011-2026 | MITO
Annual Operating Expenses Stealth BioTherapeutics Corp
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 46.3 M | - | 66.9 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 66.9 M | 46.3 M | 56.6 M |
Operating Expenses of other stocks in the Biotechnology industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
432 M | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
206 M | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
140 M | - | - | $ 86.2 M | ||
|
AlloVir
ALVR
|
46.2 M | - | 4.14 % | $ 49.1 M | ||
|
Amgen
AMGN
|
9.33 B | $ 340.0 | -0.75 % | $ 183 B | ||
|
Amneal Pharmaceuticals
AMRX
|
539 M | $ 12.32 | -0.24 % | $ 3.86 B | ||
|
Applied Molecular Transport
AMTI
|
127 M | - | - | $ 10.1 M | ||
|
Applied Therapeutics
APLT
|
74.5 M | - | - | $ 8.42 M | ||
|
I-Mab
IMAB
|
1.49 B | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.66 B | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
78.3 M | - | 2.54 % | $ 160 B | ||
|
Arcutis Biotherapeutics
ARQT
|
137 M | $ 23.27 | -1.63 % | $ 2.96 B | ||
|
Autolus Therapeutics plc
AUTL
|
145 M | $ 1.36 | -2.16 % | $ 362 M | ||
|
AVROBIO
AVRO
|
71.7 M | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
29.8 M | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
17.6 B | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
4.78 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.22 M | - | -1.52 % | $ 24.7 M | ||
|
BeiGene, Ltd.
BGNE
|
390 M | - | 0.49 % | $ 251 B | ||
|
Alterity Therapeutics Limited
ATHE
|
16.7 M | $ 3.76 | 4.35 % | $ 9.05 B | ||
|
CymaBay Therapeutics
CBAY
|
133 M | - | - | $ 3.45 B | ||
|
Advaxis
ADXS
|
22 M | - | -9.65 % | $ 45.9 M | ||
|
Aytu BioScience
AYTU
|
53.7 M | $ 2.57 | -3.38 % | $ 16.1 M | ||
|
Avid Bioservices
CDMO
|
26 M | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
177 M | - | - | $ 1.41 B | ||
|
Институт стволовых клеток человека
ISKJ
|
629 M | - | - | - | ||
|
Checkpoint Therapeutics
CKPT
|
56.2 M | - | - | $ 169 M | ||
|
Cellectar Biosciences
CLRB
|
15.3 M | $ 2.75 | 1.48 % | $ 7.17 M | ||
|
Aeterna Zentaris
AEZS
|
23 M | - | 5.93 % | $ 314 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
61.5 M | - | - | $ 231 M | ||
|
AgeX Therapeutics
AGE
|
24.2 M | - | -10.17 % | $ 12.2 K | ||
|
Concert Pharmaceuticals
CNCE
|
110 M | - | - | $ 401 M | ||
|
Aeglea BioTherapeutics
AGLE
|
210 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
66.5 M | - | - | $ 26.5 M | ||
|
CTI BioPharma Corp.
CTIC
|
47.8 M | - | - | $ 1.2 B | ||
|
AIkido Pharma
AIKI
|
179 M | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
24.7 M | - | -45.71 % | $ 1.2 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
9.17 M | - | -4.36 % | $ 27 M | ||
|
Cyclerion Therapeutics
CYCN
|
5.63 M | $ 3.48 | -16.14 % | $ 8.76 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
226 M | - | - | $ 2.18 B | ||
|
Akero Therapeutics
AKRO
|
80.2 M | - | - | $ 3.67 B | ||
|
Dynavax Technologies Corporation
DVAX
|
137 M | - | - | $ 2.02 B | ||
|
CureVac N.V.
CVAC
|
88.9 M | - | - | $ 867 M | ||
|
Dyadic International
DYAI
|
10.1 M | $ 0.88 | 1.66 % | $ 31.8 M | ||
|
BioNTech SE
BNTX
|
512 M | $ 89.62 | -1.82 % | $ 27.2 B | ||
|
Coherus BioSciences
CHRS
|
231 M | $ 1.67 | - | $ 196 M | ||
|
Akari Therapeutics, Plc
AKTX
|
17.3 M | $ 3.8 | 7.34 % | $ 256 B | ||
|
Akouos
AKUS
|
86.8 M | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
196 M | - | - | $ 28.6 M |